Online Survey to Investigate Asthma Medication Prescription and Adherence from the Perspective of Patients and Healthcare Practitioners in England

BACKGROUND: High short-acting β(2)-agonist (SABA) use and/or inhaled corticosteroid (ICS) underuse are common and are associated with poor asthma outcomes.

This study explored patients’ and healthcare practitioners’ (HCPs’) perspectives to contextualize asthma treatment patterns observed in real-world studies.

METHODS: Data were collected using online surveys from HCPs and people with asthma (≥18 years old with a confirmed asthma diagnosis of any severity) who had consented to research participation through the Clinical Practice Research Datalink.

Data were analysed using descriptive statistics.

RESULTS: In total, 76 HCPs and 63 patients were invited to take part.

Of 48 valid HCP responders, 54.2% (n=26) reported scheduling an annual asthma treatment review with their patients and 83.3% of general practitioners (n=40) had prescribed repeated inhalers at the patient’s request.

Of 47 valid patient responders, 57.4% (n=27) reported using their reliever (SABA) inhaler daily and 55.3% of patients (n=26) reported being prescribed a preventer inhaler.

Of the total patient responders, 31.9% (n=15) reported that they never used their preventer inhaler.

Consistent annual adherence with preventer inhalers was reported by 44.7% of all valid responders (n=21), while other patients admitted to using preventers intermittently.

CONCLUSION: SABA and ICS prescription patterns are driven by a combination of HCP and patient factors.

Opportunities exist to improve asthma control and behaviours around inhaler use.